Patient Perspectives on Switching from Infliximab to Infliximab-dyyb in Patients with Rheumatologic Diseases in the United States
about
Patient Perspectives on Switching from Infliximab to Infliximab-dyyb in Patients with Rheumatologic Diseases in the United States
description
scientific article published on 15 March 2019
@en
name
Patient Perspectives on Switch ...... Diseases in the United States
@en
type
label
Patient Perspectives on Switch ...... Diseases in the United States
@en
prefLabel
Patient Perspectives on Switch ...... Diseases in the United States
@en
P2093
P356
P1476
Patient Perspectives on Switch ...... Diseases in the United States
@en
P2093
Bharati Bhardwaja
Jason Chau
Taylor Ota
P356
10.1002/ACR2.1007
P577
2019-03-15T00:00:00Z